The ideal time to take your multivitamin may depend on its specific nutrients and formula, but there are generally ways to avoid common mistakes.

Collagen powders, capsules, or drinks — which form works best? Compare the benefits, costs, and effectiveness of collagen supplements for healthier joints and skin.

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

This new pill contains the same active ingredient as injectable Wegovy and Ozempic, semaglutide. It is the first GLP-1 pill ...

The FDA’s approval of a GLP-1 weight-loss pill could make these drugs easier to access and harder to ignore. People who are squeamish about needles for administering GLP-1 weight-loss drugs will soon ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

Current GLP-1 weight-loss meds need to be taken as injections, but new trial results suggest a GLP-1 in pill form could be near In an 18-month clinical trial, people with obesity and diabetes lost ...

Digestive discomfort affects us all from time to time, but it’s something few people like to talk about. On one end of the spectrum, feeling backed up can leave you bloated, sluggish, gassy and ...

Metamucil is a fiber supplement commonly taken for gut health. It can also help manage cholesterol and blood sugar. The effects of Metamucil capsules and powder are similar because they have the same ...

While the drug was safe and improved some biological markers linked to the disease, it did not slow memory or cognitive decline compared to a placebo. HealthDay News — A pill version of semaglutide, ...

Millions of people use injectable drugs like Wegovy to reach a healthier weight. But the weekly injections aren't for everybody — or every wallet. That's why pills that could achieve similar results ...

A pill version of semaglutide, the ingredient in Ozempic and Wegovy, did not slow the progress of Alzheimer's disease, drugmaker Novo Nordisk announced on Nov. 24. In two Phase III trials, researchers ...